This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Idogen Gestione
Gestione criteri di controllo 1/4
Idogen's CEO is Christina Herder, appointed in Sep 2022, they has a tenure of less than a year. Their total yearly compensation is SEK454.00K , comprised of 66.1% salary and 33.9% bonuses, including company stock and options. They directly owns 0.06% of the company’s shares, worth SEK7.56K. The average tenure of the management team and the board of directors is 1.5 years and 2.7 years respectively.
Informazioni chiave
Christina Herder
Amministratore delegato
SEK 454.0k
Compenso totale
| Percentuale dello stipendio del CEO | 66.1% |
| Mandato del CEO | less than a year |
| Proprietà del CEO | 0.06% |
| Durata media del management | 1.5yrs |
| Durata media del Consiglio di amministrazione | 2.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -SEK 44m |
| Dec 31 2022 | SEK 454k | SEK 300k | -SEK 48m |
| Sep 30 2022 | n/a | n/a | -SEK 50m |
| Jun 30 2022 | n/a | n/a | -SEK 41m |
| Mar 31 2022 | n/a | n/a | -SEK 39m |
| Dec 31 2021 | SEK 150k | n/a | -SEK 39m |
| Sep 30 2021 | n/a | n/a | -SEK 33m |
| Jun 30 2021 | n/a | n/a | -SEK 33m |
| Mar 31 2021 | n/a | n/a | -SEK 31m |
| Dec 31 2020 | SEK 150k | n/a | -SEK 27m |
Compensazione vs Mercato: Christina's total compensation ($USD42.19K) is below average for companies of similar size in the Swedish market ($USD231.64K).
Compensazione vs guadagni: Christina's compensation has increased whilst the company is unprofitable.
AMMINISTRATORE DELEGATO
Christina Herder (62 yo)
less than a year
Mandato
SEK 454,000
Compensazione
Dr. Christina Herder, Ph D., served as Independent Director for Ziccum AB (publ) since April 28, 2022 until May 2023. She is Director at Beactica AB since 2021.She is a Director at Elicera Therapeutics AB...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Acting CEO & Director | less than a year | SEK 454.00k | 0.060% SEK 7.6k | |
| Founder & Chairman of the Scientific Advisory Board | no data | SEK 150.00k | 0.17% SEK 22.0k | |
| Chief Financial Officer | 7.2yrs | Nessun dato | 0.33% SEK 42.1k | |
| Chief Technology Officer | 9.5yrs | SEK 120.74k | 0.012% SEK 1.5k | |
| Chief Medical Officer | 1.5yrs | Nessun dato | Nessun dato | |
| Chief Regulatory Officer | 1.3yrs | Nessun dato | Nessun dato |
1.5yrs
Durata media
62yo
Età media
Gestione esperta: IDOGEN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Acting CEO & Director | 6.2yrs | SEK 454.00k | 0.060% SEK 7.6k | |
| Founder & Chairman of the Scientific Advisory Board | 7.8yrs | SEK 150.00k | 0.17% SEK 22.0k | |
| Independent Chairman of the Board | 7.3yrs | SEK 407.00k | 0.15% SEK 18.9k | |
| Member of Scientific Advisory Board | 7.8yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 2.3yrs | Nessun dato | Nessun dato | |
| Independent Director | 3.2yrs | SEK 150.00k | 0.089% SEK 11.1k | |
| Member of Scientific Advisory Board | 2.3yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 2.3yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | less than a year | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | less than a year | Nessun dato | Nessun dato |
2.7yrs
Durata media
64.5yo
Età media
Consiglio di amministrazione esperto: IDOGEN's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.